US Patent Litigations are now available. Check here

Explore Argenx's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3638696Jun 26, 2024Use Of Anti Cd70 Antibody Argx-110 To Treat Acute Myeloid Leukaemia2
EP3087095Aug 7, 2019Fcrn Antagonists And Methods Of Use1